BOSTON — Representatives of some of the nation’s largest generic drug manufacturers used code words to collude with competitors to divvy up market share and coordinate price increases according to a federal lawsuit. In another email, representatives from three companies talk about coordinating “polite f-u” letters in 2014 in response to a congressional probe into price increases in the generic …
States Sue Drugmakers Over Alleged Generic Price-Fixing SchemeEnlarge this image Jose A. Bernat Bacete/Getty Images Jose A. Bernat Bacete/Getty ImagesConnecticut Attorney General William Tong has a skin condition called rosacea, and he says he takes the antibiotic doxycycline once a day for it. In 2013, the average market price of doxycycline rose from $20 to $1,829 a year later. The suit is a …
South Carolina is now one of 40 states to accuse six drug-makers of conspiring to inflate prices and fix the market for two generic drugs used to treat infections and diabetes, in a federal lawsuit. Attorney General Alan Wilson announced Sunday that the Palmetto State backs the claims echoed nationwide that the companies “entered into illegal conspiracies in order to unreasonably restrain …
Maine is among 20 states suing six generic drug-makers with a claim that the companies artificially inflated prices for an antibiotic and an oral diabetes medication. Attorney General Janet Mills says the federal lawsuit accuses the companies of manipulating prices and reducing competition for a pair of drugs that many state residents buy as lower-cost generics. She accuses the …
Kentucky has joined a multistate lawsuit alleging that a large group of pharmaceutical companies have monopolized generic drugs. Attorney General Andy Beshear called the move “straightforward and sinister.” The lawsuit alleges widespread collusion among the pharmaceutical companies to reduce competition and increase the price of generic drugs. The states allege the …
Six generic drug-makers artificially inflated and manipulated prices to reduce competition for an antibiotic and oral diabetes medication, 20 state attorneys general, led by Connecticut, said in a federal lawsuit filed Thursday. Connecticut Attorney General George Jepsen, whose office began its investigation more than two years ago into suspicious price increases of certain generic medications, …
U.S. Patent and Trademark Office Director Michelle Lee faced a barrage of questions and criticism from primarily Republican lawmakers on Tuesday at a U.S. House of Representatives’ Judiciary Committee hearing, over reports issued in recent months that took the agency to task over patent quality and employee attendance issues. A federal appeals court has ordered a federal judge in Philadelphia …
A class action lawsuit charges that Anthem Blue Cross refuses to cover name-brand medication, even when there is no equivalent generic or the generic is ineffective. In the suit, K.F. Petty says that in 2007, her doctor prescribed a medication described in the suit as “Drug X” to protect her privacy.